Abstract
Background: Convergent evidence from genetics, symptomatology and psychopharmacology imply that there are intrinsic connections between schizophrenia (SCZ), bipolar disorder (BPD) and major depressive disorder (MDD), for example, any two or even three of these disorders could co-exist in some families.
Objective: To screen out the susceptibility genes on chromosome 6 comprehensively for SCZ, BPD and MDD in a relative homogenous population in China. Method: A total of 56.400 single nucleotide polymorphism (SNPs) on chromosome 6 were genotyped by Affymetrix Genome-Wide Human SNP array 6.0 on 119 SCZ, 253 BPD (type- I), 177 MDD patients and 1000 controls. Results: Associated SNP loci on chromosome 6 were comprehensively revealed and outstanding susceptibility genes were identified including JARID2 (Homo sapiens jumonji, AT rich interactive domain 2) which plays an essential role in embryonic development and neural tube fusion process. Unexpectedly, flanking genes for all associated SNPs were replicated in an enlarged cohort of 986 SCZ patients. Conclusion: Considering all evidence, our results imply that both of bipolar disorder and major depressive disorder are subtypes of schizophrenia. Furthermore, JARID2 is an important psychosis gene in this population.Keywords: Schizophrenia, subtype, bipolar disorder, major depressive disorder, JARID2, gene.
Current Molecular Medicine
Title:A Novel Relationship for Schizophrenia, Bipolar and Major Depressive Disorder Part 6: A Hint from Chromosome 6 High Density Association Screen
Volume: 16 Issue: 9
Author(s): X. Chen, F. Long, B. Cai, X.H. Chen and G. Chen
Affiliation:
Keywords: Schizophrenia, subtype, bipolar disorder, major depressive disorder, JARID2, gene.
Abstract: Background: Convergent evidence from genetics, symptomatology and psychopharmacology imply that there are intrinsic connections between schizophrenia (SCZ), bipolar disorder (BPD) and major depressive disorder (MDD), for example, any two or even three of these disorders could co-exist in some families.
Objective: To screen out the susceptibility genes on chromosome 6 comprehensively for SCZ, BPD and MDD in a relative homogenous population in China. Method: A total of 56.400 single nucleotide polymorphism (SNPs) on chromosome 6 were genotyped by Affymetrix Genome-Wide Human SNP array 6.0 on 119 SCZ, 253 BPD (type- I), 177 MDD patients and 1000 controls. Results: Associated SNP loci on chromosome 6 were comprehensively revealed and outstanding susceptibility genes were identified including JARID2 (Homo sapiens jumonji, AT rich interactive domain 2) which plays an essential role in embryonic development and neural tube fusion process. Unexpectedly, flanking genes for all associated SNPs were replicated in an enlarged cohort of 986 SCZ patients. Conclusion: Considering all evidence, our results imply that both of bipolar disorder and major depressive disorder are subtypes of schizophrenia. Furthermore, JARID2 is an important psychosis gene in this population.Export Options
About this article
Cite this article as:
Chen X., Long F., Cai B., Chen X.H. and Chen G., A Novel Relationship for Schizophrenia, Bipolar and Major Depressive Disorder Part 6: A Hint from Chromosome 6 High Density Association Screen, Current Molecular Medicine 2016; 16 (9) . https://dx.doi.org/10.2174/1566524016666161128115135
DOI https://dx.doi.org/10.2174/1566524016666161128115135 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
Call for Papers in Thematic Issues
Molecular and Cellular Mechanisms in Vertigo / Vestibular Disorders
Vertigo and vestibular diseases are common among middle-aged and older adults, significantly increasing the risk of falls and leading to injuries and disabilities. Despite their prevalence, therapeutic advancements are hindered by a limited understanding of the underlying molecular and cellular mechanisms. This Special Issue is dedicated to bridging this gap ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Arsenic Trioxide Targets miR-125b in Glioma Cells
Current Pharmaceutical Design Type 2 Transglutaminase in Neurodegenerative Diseases: The Mitochondrial Connection
Current Pharmaceutical Design Anti-tumor Drug Targets Analysis: Current Insight and Future Prospect
Current Drug Targets Analysis of Codon Usage Patterns in the Human Papillomavirus Oncogenes
Current Bioinformatics A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer
Current Cancer Drug Targets Retinoic Acid Signaling in P19 Stem Cell Differentiation
Anti-Cancer Agents in Medicinal Chemistry An Update on Molecular Research of Pancreatic Adenocarcinoma
Anti-Cancer Agents in Medicinal Chemistry The Pathogenesis of Susceptibility to Acute Kidney Injury in the Elderly
Current Aging Science Glioblastoma Targeted Gene Therapy Based on pEGFP/p53-Loaded Superparamagnetic Iron Oxide Nanoparticles
Current Gene Therapy Prodigiosins as Anti Cancer Agents: Living Upto Their Name
Current Pharmaceutical Design Imidazo[1,2-a]pyridines: Promising Drug Candidate for Antitumor Therapy
Current Topics in Medicinal Chemistry Nanoparticles Containing Oxaliplatin and the Treatment of Colorectal Cancer
Current Pharmaceutical Design The Vitamin D/CYP24A1 Story in Cancer
Anti-Cancer Agents in Medicinal Chemistry Novel Target Sites for Drug Screening: A Special Reference to Cancer, Rheumatoid Arthritis and Parkinson’s Disease
Current Signal Transduction Therapy Structure-Function Relationships of PEDF
Current Molecular Medicine Cancer Vaccines: Emphasis on Pediatric Cancers
Current Pharmaceutical Design The MCM Complex: Its Role in DNA Replication and Implications for Cancer Therapy
Current Cancer Drug Targets Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments
Current Topics in Medicinal Chemistry Novel Therapeutic Approaches to Regulate Human Dihydrofolate Reductase Activity and Expression
Current Enzyme Inhibition Redox Control of Cardiovascular Homeostasis by Angiotensin II
Current Pharmaceutical Design